NIH-funded research R01 grant

Exploring how bacteria influence cancer development and treatment.

Official title: Interrogating the Role of Bacterial Methyl-modifying Enzymes in Pathoadaptation and Host Epigenetic Interference in Cancer

Funded at University of Tx Md Anderson Can Ctr · NIH-10999811 · Data updated 2026-11-12

This study is looking at how certain bacteria might change our genes and help cancer grow, especially in people with colorectal cancer, to find new ways to prevent and treat the disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startAugust 5, 2024
Project endJuly 31, 2029
Funding year2024
Award (this year)$692,241
NIH project number1R01CA290034-01A1
Project IDNIH-10999811 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include patients diagnosed with colorectal cancer or those at high risk for developing this type of cancer.

Less likely to help

Patients with cancers unrelated to bacterial influences or those who do not have colorectal cancer may not benefit from this research.

What this research studies

This research investigates the role of specific bacterial enzymes in the development of cancer, particularly how they may alter the human genome and contribute to tumor growth. By studying the interaction between bacteria and cancer cells in the tumor microenvironment, the researchers aim to identify potential therapeutic targets for cancer prevention and treatment. The study utilizes advanced genetic and microbiological techniques to analyze bacterial strains found in colorectal cancer patients, focusing on their impact on cancer progression.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing and treating cancer by targeting bacterial influences on tumor development.

How similar studies have gone: Previous studies have shown promising results in understanding the relationship between the microbiome and cancer, suggesting that this approach could yield significant insights.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Johnston, Christopher D — University of Tx Md Anderson Can Ctr
  • Study coordinator: Johnston, Christopher D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.